THOMAS W. HOOG

Corporate Board Profile

Tech Score: 0/100

GT Biopharma, Inc.

Filing Date	Source Excerpt
2011-07-14	Our Board has determined that each of Messrs. Thomas W. Hoog, Kenneth Eaton, Anshuman “Andy” Dube and David Saloff is an independent director as defined in The Nasdaq Stock Market listing standards. As of the date of this proxy statement, Anshuman “Andy” Dube and Thomas Hoog constitute the members of the Audit Committee. As of the date of this proxy statement, Anshuman “Andy” Dube and Thomas Hoog constitute the members of the Nominating and Governance Committee. As of the date of this proxy statement, Anshuman “Andy” Dube and Thomas Hoog constitute the members of the Compensation Committee. The following table sets forth information concerning the compensation paid to each of our non-employee directors during 2010 for their services rendered as directors. The compensation of Mr. Cataldo, who has served as our Chief Executive Officer and as a director during 2010, is described below in “Executive Compensation – Summary Compensation Table.” The following table sets forth information concerning the compensation paid to each of our non-employee directors during 2010 for their services rendered as directors. The compensation of Mr. Cataldo, who has served as our Chief Executive Officer and as a director during 2010, is described below in “Executive Compensation – Summary Compensation Table.”

Filing Date

Source Excerpt

2011-07-14

Our Board has determined that each of Messrs. Thomas W. Hoog, Kenneth Eaton, Anshuman “Andy” Dube and David Saloff is an independent director as defined in The Nasdaq Stock Market listing standards. As of the date of this proxy statement, Anshuman “Andy” Dube and Thomas Hoog constitute the members of the Audit Committee. As of the date of this proxy statement, Anshuman “Andy” Dube and Thomas Hoog constitute the members of the Nominating and Governance Committee. As of the date of this proxy statement, Anshuman “Andy” Dube and Thomas Hoog constitute the members of the Compensation Committee. The following table sets forth information concerning the compensation paid to each of our non-employee directors during 2010 for their services rendered as directors. The compensation of Mr. Cataldo, who has served as our Chief Executive Officer and as a director during 2010, is described below in “Executive Compensation – Summary Compensation Table.” The following table sets forth information concerning the compensation paid to each of our non-employee directors during 2010 for their services rendered as directors. The compensation of Mr. Cataldo, who has served as our Chief Executive Officer and as a director during 2010, is described below in “Executive Compensation – Summary Compensation Table.”

Data sourced from SEC filings. Last updated: 2025-10-12